Dementias Platform UK (DPUK) is pleased to announce it has signed a memorandum of understanding with the newly launched Korea Dementia Research Center (KDRC).
An online course explores the emerging neuroimaging technique of PET-MR, in which PET and MRI scans are run simultaneously to produce dynamic, high-quality images of the brain.
DPUK director Professor John Gallacher says the decision to approve the Alzheimer's drug aducanumab for use in the US is 'exciting news' for dementia research.
Dementias Platform UK is to host access to a new cellular model platform that will help researchers explore risk factors that contribute to the development of Alzheimer's disease.
People consume less alcohol as the price of food increases, suggesting this may influence the decision to buy it, according to a new study led by Cardiff University and carried out in the DPUK Data Portal.
Researchers have developed a more efficient method of assessing symptom change in people with ulcerative colitis \u2013 a form of inflammatory bowel disease (IBD).
People who experienced head injuries in their 50s or younger score lower than expected on cognitive tests at age 70, according to a study led by UCL researchers and part-funded by DPUK.
Dementias Platform UK (DPUK) has been featured as a case study in the latest report from Alzheimer Europe, a non-profit, non-governmental organisation aiming to make dementia a priority across Europe.
Hearing loss is known to increase a person\u2019s risk of dementia, but new research demonstrates that using hearing aids for hearing difficulties can protect against the condition.
A decline in cognitive ability is one of the hallmarks of dementia. But how do researchers and clinicians accurately measure these changes in symptoms?
Researchers based at UCL have found that blood tests measuring the protein amyloid \u2013 a hallmark of Alzheimer's disease \u2013 could radically reduce the cost of clinical trials and potentially open the door to treating the disease earlier.
Researchers at Oxford University are recruiting volunteers aged 50+ who have either mild cognitive impairment (MCI) or early-stage dementia, as well as neurologically healthy people as an essential comparison to those with memory impairment.
A new paper details what the DPUK volunteer recontact register is and how it can be used by researchers to recruit highly characterised participants to brain health studies.
![\"An](\"https://www.dementiasplatform.uk/news-and-media/latest-news/dpuk-and-korea-dementia-research-center-to-work-together-for-global-benefit/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n